UBS Asset Management Form 8.3 - Takeda Pharmaceutical (5323M)
08 January 2019 - 11:29PM
UK Regulatory
TIDMSHP TIDM0RN3
RNS Number : 5323M
UBS Asset Management
08 January 2019
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: UBS Asset Management
*
(b) Owner or controller of interests
and short positions disclosed, if
different from 1(a):
The naming of nominee or vehicle
companies is insufficient. For a
trust, the trustee(s), settlor and
beneficiaries must be named.
----------------------
(c) Name of offeror/offeree in relation Takeda Pharmaceutical
to whose relevant securities this Co Ltd
form relates:
Use a separate form for each offeror/offeree
----------------------
(d) If an exempt fund manager connected
with an offeror/offeree, state this n/a
and specify identity of offeror/offeree:
----------------------
(e) Date position held/dealing undertaken: 07 Jan 2019
For an opening position disclosure,
state the latest practicable date
prior to the disclosure
----------------------
(f) In addition to the company in NO
1(c) above, is the discloser making
disclosures in respect of any other
party to the offer?
If it is a cash offer or possible
cash offer, state "N/A"
----------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security: Ordinary shares
Interests Short positions
----------------------- -----------------------
Number % Number %
-------------- ------- -------------- -------
(1) Relevant securities
owned and/or controlled: 11,356,399 1.45 0 0.00
-------------- ------- -------------- -------
(2) Cash-settled derivatives: 0 0.00 0 0.00
-------------- ------- -------------- -------
(3) Stock-settled derivatives
(including options) and
agreements to purchase/sell: 0 0.00 0 0.00
-------------- ------- -------------- -------
TOTAL: 11,356,399 1.45 0 0.00
-------------- ------- -------------- -------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security
in relation to which subscription
right exists:
Details, including nature
of the rights concerned and
relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of securities Price per unit
security
Ordinary shares PURCHASE 500 4,065.000000
JPY
---------------- --------------------- ---------------
Ordinary shares PURCHASE 2,500 3,995.000000
JPY
---------------- --------------------- ---------------
Ordinary shares SALE 4,600 3,995.000000
JPY
---------------- --------------------- ---------------
Ordinary shares SALE 7,000 4,065.000000
JPY
---------------- --------------------- ---------------
TOTAL PURCHASE 3,000
------------------------------------ --------------------- ---------------
TOTAL SALE 11,600
------------------------------------ --------------------- ---------------
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description e.g. opening/closing reference unit
security e.g. CFD a long/short position, securities
increasing/reducing
a long/short position
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of relevant description purchasing, of securities price e.g. American, date money
security e.g. call selling, to which per unit European paid/
option varying etc. option etc. received
relates per unit
(ii) Exercise
Class of relevant Product description Exercising/ Number of Exercise
security e.g. call option exercised against securities price per
unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Details Price per
security e.g. subscription, unit (if applicable)
conversion
Ordinary shares TRANSFER IN 2,100 3,705.000000
JPY
-------------------- -------------- ----------------------
Ordinary shares TRANSFER OUT 2,100 4,545.978095
JPY
-------------------- -------------- ----------------------
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any
agreement or understanding, formal or informal, relating
to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the person making
the disclosure and any party to the offer or any person
acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not
be included. If there are no such agreements, arrangements
or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding,
formal or informal, between the person making the disclosure
and any other person relating to:
(i) the voting rights of any relevant securities under
any option; or
(ii) the voting rights or future acquisition or disposal
of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings,
state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 08/01/2019
Contact name: Mr James Mortimer
------------------
Telephone number: +44 20 7901 5828
------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service and must also be emailed to the
Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market
Surveillance Unit is available for consultation in relation to the
Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
* this report is on behalf of:
UBS AG (UBS Asset Management operating in Switzerland)
UBS Asset Management (Americas) Inc.
UBS Asset Management (Australia) Ltd
UBS Asset Management (Hong Kong) Limited
UBS Asset Management (Singapore) Ltd
UBS Asset Management (Taiwan) Ltd
UBS Asset Management (UK) Ltd
UBS La Maison de Gestion
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RETCKFDBBBKDFDK
(END) Dow Jones Newswires
January 08, 2019 07:29 ET (12:29 GMT)
Shire (LSE:SHP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Shire (LSE:SHP)
Historical Stock Chart
From Dec 2023 to Dec 2024
